Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

DiscoveRx Corporation, Applied Biosystems Sign Distribution Agreement for HitHunter HTS Assays

Photonics.com
Aug 2001
FOSTER CITY AND FREMONT, Calif., Aug. 6 -- Applied Biosystems Group, an Applera Corporation business, and DiscoveRx Corporation have signed a co-exclusive agreement for distribution of the chemiluminescence-based HitHunter drug discovery tools. HitHunter assays and tools, which feature enzyme-fragment complementation for labeling and detection, are used to build successful precision, homogeneous, high-throughput assays for a wide variety of targets. Manufactured by DiscoveRx, HitHunter assays are formulated with Applied Biosystems Tropix brand proprietary chemiluminescence substrates to enable high-throughput screening (HTS). The agreement also provides for future strategic collaborations involving product research and development.

"We are very pleased to welcome Applied Biosystems as a distribution partner for our HitHunter platform," said Pyare Khanna, CEO of DiscoveRx.


News & Features

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.